 |
Like most businesses, biologic innovators and CDMOs must allocate their finite resources to the best uses to be successful. While quality-related activities are not necessarily considered revenue-generating, they are certainly critical for success. Attention to quality early helps mitigate risks, improve operations, and reduce the costs of poor quality (COPQ). Working with an experienced distribution and service provider can help reduce the cost of quality to accelerate speed to market and maximize scale-up. The raw materials supply chain is too vital to leave to chance. Entrusting supply chain management to an organization with deep supply chain experience—one that can anticipate potential pitfalls, mitigate those risks, and provide operational efficiencies—can help insulate companies from COPQ. This allows those companies to concentrate on allocating their resources to what they do best: producing life-changing drugs. In this whitepaper, you will learn about:
|
